Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Some people transitioning from high-dose tirzepatide or semaglutide report a temporary period where appetite suppression feels weaker before retatrutide glucagon receptor effects begin contributing meaningfully
These findings suggest that GLP-1 medications are doing something biologically distinct in muscle beyond simply causing weight loss
Another Danish study is also investigating the effect of GLP-1R agonists on cerebral blood flow (NCT02829502)
They have different side effect profiles, costs, and availability though
Some people notice changes in energy levels
An increased secretion of GLP-1 may be responsible for postprandial reactive hypoglycemia, whereas a decreased secretion of GLP-1 may be responsible for obesity
